Christopher Aaron Bristow

机构：The University of Texas MD Anderson Cancer Center · ORCID：0009-0009-9266-6849

发表论文 258 篇 · 总被引 31120 次 · h-index 46

代表论文

• Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer (2024 · Cancer Discovery · 被引 274)
• Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance (2024 · Nature Cancer · 被引 59)
• Epigenome Reprogramming Through H3K27 and H3K4 Trimethylation as a Resistance Mechanism to DNA Methylation Inhibition in BRAFV600E-Mutated Colorectal Cancer (2024 · Clinical Cancer Research · 被引 20)
• CDK2 inhibition enhances CDK4/6 inhibitor antitumor activity in comprehensive breast cancer PDX model screen (2025 · npj Breast Cancer · 被引 9)
• A TRAILR2/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer (2024 · mAbs · 被引 3)
• Reprogramming of Cellular Plasticity via ETS and MYC Core-Regulatory Circuits during Response to MAPK Inhibition in BRAF -Mutant Colorectal Cancer (2026 · Clinical Cancer Research · 被引 1)